Previous 10 | Next 10 |
PAVmed Inc. (PAVM) Q4 2021 Earnings Conference Call March 29, 2022, 04:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Frank Takkinen - Lake Street Capital Mark...
PAVmed press release (NASDAQ:PAVM): Q4 Non-GAAP EPS of -$0.15. Revenue of $300M. For further details see: PAVmed Non-GAAP EPS of -$0.15, revenue of $300M
Conference call to be held today at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health...
PAVmed (NASDAQ:PAVM) is scheduled to announce Q4 earnings results on Tuesday, March 29th, after market close. The consensus EPS Estimate is -$0.14 (-16.7% Y/Y) and the consensus Revenue Estimate is $0.46M Over the last 2 years, PAVM has beaten EPS estimates 63% of the time and has beaten reve...
Lucid Diagnostics (NASDAQ:LUCD), majority-owned unit of PAVmed (NASDAQ:PAVM), said the first patient was enrolled in a Department of Defense funded study of its EsoGuard Esophageal DNA Test in at-risk patients with gastroesophageal reflux disease (GERD). The study is being carried out by inve...
Cleveland VA enrolls first patient in DoD-funded study of EsoGuard’s impact in improving efficiency and cost-effectiveness of early detection of esophageal precancer Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage cancer prevention...
Lucid Diagnostics (NASDAQ:LUCD), a majority-owned subsidiary of PAVmed (NASDAQ:PAVM), launched Lucid Test Centers in three new metropolitan areas—Seattle, Washington; Portland, Oregon; and Boise, Idaho. The companies said that in these cities patients with chronic heartburn, also ...
Gainers: Kidpik (PIK) +79%. Eiger BioPharmaceuticals (EIGR) +42%. Mullen Automotive (MULN) +36%. Indonesia Energy (INDO) +29%. PAVmed (PAVM) +29%. Marine Petroleum (MARPS) +29%. Summer Infant (SUMR) +28%. Innodata (INOD) +27%. Houston American Energy (HUSA) +26%. Nine Energy Service (NINE) +2...
Commercial-stage med-tech firm, PAVmed (PAVM +7.1%), is trading higher after announcing the first human implants using the company’s PortIO Intraosseous Infusion System. As part of the first-in-human study in Colombia, South America, doctors at the Clinica Porto Azul in Barranquilla ha...
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a diversified commercial-sta...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...